Nebulizer Market Size, Share, Growth Analysis, By Application(COPD, Cystic Fibrosis, Asthma, Others), By Type(Jet, Mesh, Ultrasonic), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2627 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 64 |Figures: 77

Nebulizer Market Insights

Nebulizer Market size was valued at USD 1.16 billion in 2022 and is poised to grow from USD 1.23 billion in 2023 to USD 1.97 billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031)

The robust growth of the Nebulizer market can be attributed to several key factors. These include the rising incidence rate of chronic respiratory diseases, a growing demand for home healthcare devices, and an increasing geriatric population.

Notably, Chronic Obstructive Pulmonary Disease (COPD) ranks as the fourth leading cause of death in the United States, as reported by the Centers for Disease Control and Prevention (CDC). This prevalence is driven by factors such as the consumption of alcohol, tobacco, and ultra-processed products, including sugar-sweetened beverages, among others, particularly in North America.

In fact, CDC data indicates that approximately 14% of deaths in adults aged 30 to 70 years in North America can be attributed to tobacco consumption. These insights highlight the strong correlation between the increasing prevalence of respiratory diseases and the need for effective Nebulizer in the market.

Furthermore, according to the World Health Organization (WHO), COPD accounted for approximately 3.23 million deaths worldwide. However, positive initiatives such as the "Global Alliance against Chronic Respiratory Diseases" are expected to enhance the rates of diagnosis and treatment for respiratory disorders, consequently driving the market for nebulizers.

These efforts aim to improve the management and prevention of chronic respiratory diseases, leading to increased demand for advanced respiratory devices like nebulizers. This indicates a promising outlook for the market as it aligns with global efforts to address and mitigate the impact of respiratory diseases on public health.

US Nebulizer Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 1.03 billion

Largest Segment

Jet

Fastest Growth

Jet

Growth Rate

6.1% CAGR

Global Nebulizer Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Nebulizer Market Segmental Analysis

The global nebulizer market is segmented on the application, type, end use and region. By application, the market is segmented into copd, cystic fibrosis, asthma, and others. By end use, the market is segmented into hospitals, emergency centers, home healthcare. By type, the market is segmented into jet, mesh, ultrasonic. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Nebulizer Market Analysis by Type

Jet nebulizers are projected to hold the largest market share in the global nebulizer market during the forecast period. These devices are easy to handle and have a design that efficiently delivers drugs, making them a preferred choice over the years. Additionally, the market offers a range of designs for nebulizers, including jet nebulizers with features such as corrugated tubes, collection bags, breath-enhanced mechanisms, and breath-actuated functionality, among others.

Due to technologically improved, small-sized devices that reduce drug loss, the mesh nebulizers market segment is anticipated to experience substantial expansion. The market for mesh nebulizers is expected to further expand due to their accurate drug delivery to the lungs and lower residual volumes, leading to greater commercial acceptance. Key players in the market offer various products, such as Omron Corporation's MicroAIR U100, which is a compact and travel-ready nebulizer utilizing mesh technology, and Philips Healthcare's Aeroneb Go, a portable nebulizer based on Aerogen's vibrating mesh technology for patients in need of respiratory aerosol therapy. These innovative mesh nebulizer options contribute to the market's growth and cater to the evolving needs of healthcare professionals and patients.

Nebulizer Market Analysis by Application

The COPD segment is anticipated to dominate the global nebulizer market during the forecast period, primarily driven by the increasing prevalence of COPD. Advancements in technology have led to the development of more portable and patient-friendly nebulizers. This enables individuals with COPD to use nebulizers outside of acute care settings, such as clinics or hospitals, which in turn fuels the growth of this segment. Companies investing in research and development to advance nebulizer technologies further stimulate segment expansion.

The asthma segment is expected to witness significant market growth in the forecast period. The growing prevalence of asthma globally, coupled with government organizations and non-governmental organization (NGO) activities focused on creating awareness, are key factors driving the growth of this segment. These initiatives aim to address the challenges posed by asthma and promote better management and treatment options, thus supporting the expansion of the nebulizer market for asthma-related care.

Global Nebulizer Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Nebulizer Market Regional Insights

North America held a significant share of over 30% in the nebulizer market in 2022, primarily driven by the increasing prevalence of respiratory disorders and proactive efforts by the government. Factors such as favorable reimbursement scenarios, growing customer awareness, and a well-established healthcare infrastructure have contributed to the region's dominance. The introduction of technologically advanced nebulizer devices and favorable reimbursement policies in North America are expected to further drive market growth. Additionally, the rising geriatric population in the United States has led to an increase in surgical procedures, further supporting market expansion in the region. It is projected that the number of Americans aged 65 and older will more than double in the next four decades, reaching 80 million by 2040. These demographic trends highlight the potential for sustained growth in the North American nebulizer market as the demand for respiratory care and surgical interventions continues to rise.

The Asia Pacific region is projected to witness the highest growth rate in the nebulizer market during the forecast period, attributed to several factors. The region's large geriatric population, coupled with a growing focus on preventive care and government initiatives promoting technological innovations, are driving the market's expansion. Increased healthcare expenditure and rising patient awareness have created a significant demand for nebulizer devices in the region. Moreover, the presence of low-cost manufacturing sites and favorable taxation policies in various countries within the region has successfully attracted foreign players to invest in the market.

Global Nebulizer Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Nebulizer Market Dynamics

Nebulizer Market Drivers

Increasing Prevalence of Respiratory Disorders

  • The rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis is a significant driver for the nebulizer market. These conditions require effective medication delivery to the respiratory system, and nebulizers play a crucial role in delivering medications directly to the lungs.
  • There is a growing preference for managing respiratory conditions in the comfort of home settings rather than in hospitals or clinics. Nebulizers play a vital role in home healthcare as they allow patients to self-administer medication, reducing the need for frequent hospital visits. This shift toward home-based care is driving the demand for nebulizers.

Nebulizer Market Restraints

Limited Reimbursement Policies

  • Reimbursement policies for nebulizer treatments may be limited or inconsistent. This lack of comprehensive coverage and reimbursement can impact the affordability and accessibility of nebulizer devices and medications for patients. It poses a barrier for patients seeking nebulizer therapy, thus limiting market growth.

Request Free Customization of this report to help us to meet your business objectives.

Nebulizer Market Competitive Landscape

Companies are implementing methods including new product development, acquisitions, and partnership with other firms or research institutes to set their products apart from those of the other market participants.

Nebulizer Market Top Player’s Company Profiles

  • Koninklijke Philips N.V. (Netherlands)
  • Drive DeVilbiss Healthcare (United States)
  • Medline Industries, Inc. (United States)
  • GF Health Products, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Allied Healthcare Products, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Teleflex Incorporated (United States)
  • Fisons plc (United Kingdom)
  • GE Healthcare (United States)
  • Medtronic plc (Ireland)
  • Trudell Medical International (Canada)
  • DeVilbiss Healthcare LLC (United States)
  • Drive Medical (United States)
  • Rossmax International Ltd. (Switzerland)
  • Smiths Medical (United States)
  • Salter Labs (United States)
  • Vyaire Medical, Inc. (United States)
  • Clement Clarke International Ltd. (United Kingdom)

Nebulizer Market Recent Developments

  • In June 2023, Aerogen announced the launch of its new AeroChamber Plus Valved Holding Chamber in the United States. The AeroChamber Plus is a valved holding chamber that helps to improve the delivery of medication to the lungs.
  • In April 2023, Philips Respironics launched its new InnoSpire Go Nebulizer in Europe. The InnoSpire Go is a lightweight, portable nebulizer that is powered by a rechargeable battery.
  • In March 2023, Omron Healthcare announced the launch of its new generation NE-U100 Mesh Nebulizer in the United States. The NE-U100 is a compact, portable nebulizer that uses mesh technology to deliver medication in a fine mist.

Nebulizer Key Market Trends

  • The nebulizer market is experiencing continuous advancements in technology, leading to the development of more efficient and user-friendly devices. For example, the introduction of mesh nebulizers, which utilize vibrating mesh technology to generate a fine mist of medication, has gained popularity due to their compact size, portability, and minimized drug loss. These advancements in technology are improving drug delivery and enhancing patient experience

Nebulizer Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the market is witnessing the adoption of nebulizers for drug development by pharmaceutical companies. The Asia Pacific region is expected to witness significant growth due to its large geriatric population, increasing focus on preventive care, and government initiatives promoting technological innovations. With ongoing research and development efforts and a growing demand for efficient respiratory care, the nebulizer market is poised for further expansion in the coming years. The global nebulizer market is experiencing steady growth driven by factors such as the increasing prevalence of respiratory diseases, advancements in technology, and the rising geriatric population.

Report Metric Details
Market size value in 2022 USD 1.16 billion
Market size value in 2031 USD 1.97 billion
Growth Rate 6.1%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Application
    • COPD, Cystic Fibrosis, Asthma, Others
  • Type
    • Jet, Mesh, Ultrasonic
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Koninklijke Philips N.V. (Netherlands)
  • Drive DeVilbiss Healthcare (United States)
  • Medline Industries, Inc. (United States)
  • GF Health Products, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Allied Healthcare Products, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Teleflex Incorporated (United States)
  • Fisons plc (United Kingdom)
  • GE Healthcare (United States)
  • Medtronic plc (Ireland)
  • Trudell Medical International (Canada)
  • DeVilbiss Healthcare LLC (United States)
  • Drive Medical (United States)
  • Rossmax International Ltd. (Switzerland)
  • Smiths Medical (United States)
  • Salter Labs (United States)
  • Vyaire Medical, Inc. (United States)
  • Clement Clarke International Ltd. (United Kingdom)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Nebulizer Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Nebulizer Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Nebulizer Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Nebulizer Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Nebulizer Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Nebulizer Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nebulizer Market size was valued at USD 1.16 billion in 2022 and is poised to grow from USD 1.23 billion in 2023 to USD 1.97 billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031)

Companies are implementing methods including new product development, acquisitions, and partnership with other firms or research institutes to set their products apart from those of the other market participants. 'Laboratories Omron Corporation (Japan)', 'Koninklijke Philips N.V. (Netherlands)', 'PARI GmbH (Germany)', 'Drive DeVilbiss Healthcare (United States)', 'Medline Industries, Inc. (United States)', 'GF Health Products, Inc. (United States)', 'Briggs Healthcare (United States)', 'Agilent Technologies, Inc. (United States)', 'Allied Healthcare Products, Inc. (United States)', 'Becton, Dickinson and Company (United States)', 'Teleflex Incorporated (United States)', 'Fisons plc (United Kingdom)', 'GE Healthcare (United States)', 'Medtronic plc (Ireland)', 'Trudell Medical International (Canada)', 'DeVilbiss Healthcare LLC (United States)', 'Drive Medical (United States)', 'Rossmax International Ltd. (Switzerland)', 'Smiths Medical (United States)', 'Salter Labs (United States)', 'Vyaire Medical, Inc. (United States)', 'Clement Clarke International Ltd. (United Kingdom)'

The rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis is a significant driver for the nebulizer market. These conditions require effective medication delivery to the respiratory system, and nebulizers play a crucial role in delivering medications directly to the lungs.

The nebulizer market is experiencing continuous advancements in technology, leading to the development of more efficient and user-friendly devices. For example, the introduction of mesh nebulizers, which utilize vibrating mesh technology to generate a fine mist of medication, has gained popularity due to their compact size, portability, and minimized drug loss. These advancements in technology are improving drug delivery and enhancing patient experience

North America held a significant share of over 30% in the nebulizer market in 2022, primarily driven by the increasing prevalence of respiratory disorders and proactive efforts by the government. Factors such as favorable reimbursement scenarios, growing customer awareness, and a well-established healthcare infrastructure have contributed to the region's dominance. The introduction of technologically advanced nebulizer devices and favorable reimbursement policies in North America are expected to further drive market growth. Additionally, the rising geriatric population in the United States has led to an increase in surgical procedures, further supporting market expansion in the region. It is projected that the number of Americans aged 65 and older will more than double in the next four decades, reaching 80 million by 2040. These demographic trends highlight the potential for sustained growth in the North American nebulizer market as the demand for respiratory care and surgical interventions continues to rise.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35A2627

$5,300
BUY NOW GET FREE SAMPLE